rs11713169 — NLGN1

NLGN1 — The Synapse Scaffold Behind Motion Sickness Susceptibility

About one in three people is highly susceptible to motion sickness. For decades this variation was assumed to be mostly psychological or a matter of inner-ear anatomy, but the first genome-wide association study of motion sickness¹¹ first genome-wide association study of motion sickness
Hromatka et al. Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis. Human Molecular Genetics, 2015 — in 80,494 individuals from 23andMe — showed the difference is partly genetic, and one of the strongest signals sits inside NLGN1, the gene that builds neuroligin 1.

rs11713169 is an intronic variant within NLGN1 on chromosome 3 (3q26.31). The C allele reached genome-wide significance (P = 5.9×10⁻¹³, beta = 0.052) for increased motion sickness susceptibility. The C allele is present in about 15% of Europeans and only 3% of Africans; roughly 75% of people globally carry two A alleles and have no elevated genetic susceptibility from this locus.

The Mechanism

Neuroligin 1²² Neuroligin 1
NL1, encoded by NLGN1, is a postsynaptic transmembrane cell adhesion protein found exclusively at excitatory (glutamatergic) synapses. Its extracellular domain binds presynaptic β-neurexins³³ β-neurexins
a family of presynaptic cell adhesion molecules that form the trans-synaptic bridge required for synapse formation and maturation, creating the structural bridge that recruits and aligns NMDA and AMPA receptors at the postsynaptic density.

Wu et al. 2019⁴⁴ Wu et al. 2019
Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. Neuron demonstrated that NL1 performs two mechanistically separate functions: its intracellular domain maintains baseline NMDA receptor levels at the synapse, while its trans-synaptic neurexin interaction is required for NMDA-dependent long-term potentiation (LTP) and dendritic spine expansion. Deleting NL1 abolishes the structural plasticity associated with LTP. This places NL1 directly at the intersection of synapse maintenance and activity-dependent learning.

Motion sickness habituation — the process by which the brain learns to suppress nausea responses after repeated exposure to provocative motion — requires exactly this kind of NMDA-dependent synaptic plasticity. Vestibular nucleus neurons undergo NMDA receptor-driven CREB activation and upregulate inhibitory GABAA receptors⁵⁵ Vestibular nucleus neurons undergo NMDA receptor-driven CREB activation and upregulate inhibitory GABAA receptors
Wang et al. 2012, Brain Research during repeated rotation training, while hippocampal CA1 encodes the stored motion pattern via CaMKII/CREB signaling⁶⁶ hippocampal CA1 encodes the stored motion pattern via CaMKII/CREB signaling
Wang et al. 2017, Scientific Reports — allowing the nervous system to anticipate rather than react to familiar motion. NLGN1 variation that subtly alters NMDA-dependent plasticity at excitatory synapses throughout these circuits is a plausible mechanism for the observed genetic effect on habituation efficiency.

The Evidence

The signal at rs11713169 emerged from the Hromatka et al. 2015 GWAS⁷⁷ Hromatka et al. 2015 GWAS
Human Molecular Genetics of 80,494 individuals — the first and largest genetic study of motion sickness ever conducted. The study identified 35 SNPs at genome-wide significance (P < 5×10⁻⁸), and rs11713169 was among the strongest hits (P = 5.9×10⁻¹³). The authors grouped associated genes into three categories: balance and vestibular development (PVRL3, TSHZ1), neurological processes including central habituation (NLGN1), and glucose homeostasis. The study also documented sex-specific effects, with up to three times stronger genetic effects in women than men at some loci.

The evidence for NL1's specific molecular role in excitatory synaptic plasticity is substantial and converges from multiple independent laboratories and model systems, supporting the mechanism by which intronic NLGN1 variation would modulate motion sickness susceptibility through altered synaptic plasticity efficiency in vestibular and hippocampal circuits.

Practical Actions

Motion sickness has effective management strategies that work independently of genotype — but knowing you carry the C allele provides a biological reason to invest in them proactively. H1-antihistamines (dimenhydrinate, meclizine) are the primary pharmacological option; they block histaminergic vestibular-cerebellar signalling that amplifies the sensory-mismatch response.

Habituation remains the most effective non-pharmacological approach⁸⁸ Habituation remains the most effective non-pharmacological approach
Keshavarz & Golding 2022, Current Opinion in Neurology. Graded exposure — beginning with mild motion and progressively increasing challenge over days to weeks — builds the stored internal motion model in hippocampal circuits. An important caveat: medications that suppress symptoms during exposure can slow habituation. If your goal is long-term adaptation rather than single-event relief, graded unmedicated exposure is more effective than relying on antihistamines.

Interactions

The GWAS that identified rs11713169 also found rs10514168 (near TSHZ1) as a motion-sickness locus via vestibular development pathways. Both variants contribute additively to susceptibility through different mechanisms — rs10514168 via inner-ear development and rs11713169 via central synaptic habituation. Carrying risk alleles at both loci further elevates baseline susceptibility.

Sex modifies the effect: the Hromatka study found effects up to three times stronger in women at some motion-sickness loci. Whether rs11713169 specifically shows a sex-stratified effect was not individually reported for this variant.